Key Financial Data Of Reporting Company

Fuji Pharma Co.,Ltd. - Filing #7357403

Concept As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-09-30
2022-10-01 to
2023-09-30
As at
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
10,746,000,000 JPY
40,889,000,000 JPY
9,996,000,000 JPY
Ordinary profit (loss)
-96,000,000 JPY
4,519,000,000 JPY
1,579,000,000 JPY
Net assets
41,982,000,000 JPY
41,177,000,000 JPY
38,424,000,000 JPY
Total assets
84,583,000,000 JPY
85,332,000,000 JPY
80,698,000,000 JPY
Basic earnings (loss) per share
112.73
141.37
45.88
Diluted earnings per share
Equity-to-asset ratio
0.496 xbrli:pure
0.483 xbrli:pure
0.476 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.